Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Landray

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2009
Dual blockade of the renin-angiotensin system: are two better than one?Richard Haynes, Philip Mason, Kazem Rahimi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2014
Neprilysin inhibition in chronic kidney diseaseParminder Judge, Richard Haynes, Martin J Landray, et al.
BMJ (Clinical Research Ed.)|October 5, 2002
ABC of antithrombotic therapy: An overview of antithrombotic therapyAndrew D Blann, Martin J Landray, Gregory Y H Lip
The Lancet. Psychiatry|April 8, 2023
Fast tracking informative clinical trials: lessons for mental healthStefan M Gold, Martin J Landray, Nick Medhurst, et al.
Clinical Medicine (London, England)|September 29, 2023
Delivering trials in the NHS: more than worth itRichard Haynes, Marion Mafham, Cheng Hock Toh, et al.
Lancet (London, England)|March 11, 2015
Alemtuzumab induction therapy in kidney transplantation - Authors' replyRichard Haynes, Colin Baigent, Martin J Landray, et al.
Plos One|November 1, 2011
Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysisMarion Mafham, Jonathan Emberson, Martin J Landray, et al.
JAMA|October 11, 2018
Trends in the Incidence and Recurrence of Inpatient-Treated Spontaneous Pneumothorax, 1968-2016Rob J Hallifax, Raph Goldacre, Martin J Landray, et al.
Clinical Trials (London, England)|April 22, 2016
Enhancing clinical evidence by proactively building quality into clinical trialsAnn Meeker-O'Connell, Coleen Glessner, Mark Behm, et al.
Lancet (London, England)|August 1, 2014
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial, Richard Haynes, Paul Harden, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2009
Dual blockade of the renin-angiotensin system: are two better than one?Richard Haynes, Philip Mason, Kazem Rahimi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2014
Neprilysin inhibition in chronic kidney diseaseParminder Judge, Richard Haynes, Martin J Landray, et al.
BMJ (Clinical Research Ed.)|October 5, 2002
ABC of antithrombotic therapy: An overview of antithrombotic therapyAndrew D Blann, Martin J Landray, Gregory Y H Lip
The Lancet. Psychiatry|April 8, 2023
Fast tracking informative clinical trials: lessons for mental healthStefan M Gold, Martin J Landray, Nick Medhurst, et al.
Clinical Medicine (London, England)|September 29, 2023
Delivering trials in the NHS: more than worth itRichard Haynes, Marion Mafham, Cheng Hock Toh, et al.
Lancet (London, England)|March 11, 2015
Alemtuzumab induction therapy in kidney transplantation - Authors' replyRichard Haynes, Colin Baigent, Martin J Landray, et al.
Plos One|November 1, 2011
Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysisMarion Mafham, Jonathan Emberson, Martin J Landray, et al.
JAMA|October 11, 2018
Trends in the Incidence and Recurrence of Inpatient-Treated Spontaneous Pneumothorax, 1968-2016Rob J Hallifax, Raph Goldacre, Martin J Landray, et al.
Clinical Trials (London, England)|April 22, 2016
Enhancing clinical evidence by proactively building quality into clinical trialsAnn Meeker-O'Connell, Coleen Glessner, Mark Behm, et al.
Lancet (London, England)|August 1, 2014
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial, Richard Haynes, Paul Harden, et al.
Pageof 12